Latest Institutional Placement News

Alicanto Minerals (ASX:AQI) has secured A$30 million through an institutional placement to fund an aggressive drilling campaign at its Mt Henry Gold Project in Western Australia, boosting its cash reserves to about A$41 million ahead of a resource update later this year.

ImpediMed has successfully closed an oversubscribed Share Purchase Plan, raising $2.1 million following a $13.2 million institutional placement. The strong shareholder response underscores confidence ahead of a key shareholder vote.

Barton Gold has secured $25.9 million through an institutional placement, fully funding critical resource upgrades, feasibility studies, and drilling at its key South Australian gold and silver projects.

Eden Innovations has wrapped up the second tranche of its $4 million institutional placement, issuing over 14 million shares at 18 cents each. The capital injection finalises the raise announced in April, with shares issued under ASX rules and ranking equally with existing stock.

DXN Limited has secured A$7 million from institutional investors to fund delivery of its maiden AI HPC modular data centre contract and expand manufacturing capacity in Southeast Asia.

Peninsula Energy has completed a fully underwritten A$36.1 million equity raising, supplemented by a US$30 million convertible debt facility, bolstering its financial firepower as it ramps up uranium production at its Lance Project.

Lindian Resources has cancelled 13 million performance rights held by a former executive chairman, sparking uncertainty as a potential $10 million claim looms.

EBR Systems has secured A$106.4 million through a fully underwritten institutional placement and entitlement offer, positioning the company for further commercial expansion of its wireless cardiac pacing technology.

Tetratherix Limited (ASX:TTX) has launched a $2 million share purchase plan offering eligible Australian and New Zealand shareholders the chance to buy shares at a 2% discount to recent trading prices. The non-underwritten SPP opens on 4 June and closes on 18 June 2026.

Racura Oncology has secured $31.2 million in funding to advance its lead cancer drug RC220, including a strategic $1 million private placement to a specialist healthcare investor.

Arafura Rare Earths has officially opened its share purchase plan following ASIC lodgement, while also dispatching notices for a July extraordinary general meeting in Perth.

Barton Gold has raised $25.5 million through an institutional placement, fully funding critical feasibility studies and resource upgrades across its Challenger, Tunkillia, and Tolmer projects in South Australia.